‘Ozempic Babies’ Concerns? Study Finds High GLP-1 Drug Use Among Young Women
A new study has revealed that over 75% of young adults aged 16-44 taking medications like Ozempic, Wegovy and Mounjaro…
Author: The Wellness Guy
Nestle Hopes to Cash In on Ozempic Craze with Weight Loss Frozen Meals
Food giant Nestle is aiming to capitalize on the surge in use of anti-obesity medications like Ozempic and Wegovy. The…
What Happens When You Stop Taking Ozempic?
The article explores what can occur after discontinuing the popular weight loss drug Ozempic (semaglutide) based on research and expert…
Weighing the Costs and Side Effects of Popular Weight Loss Drugs
There are high costs and potential side effects of the new generation of weight loss medications like semaglutide (Wegovy) and…
Hims & Hers Selling Wegovy and Ozempic Stirs Controversy
The telehealth companies Hims & Hers have started selling the weight loss drug Wegovy (semaglutide) and the diabetes drug Ozempic…
Muscle-Preserving Drugs in Development to Complement Weight Loss from GLP-1 Medications
As GLP-1 drugs like semaglutide (Wegovy) and tirzepatide (Zepbound) are producing unprecedented weight loss, concern has arisen about the proportion…
Beware of Muscle Loss – A Potential Side Effect of Popular GLP-1 Drugs
While GLP-1 agonist drugs like Ozempic, Wegovy, Mounjaro have shown great efficacy for diabetes and weight loss, some studies have…
Novo Nordisk’s Semaglutide Shows Lifesaving Potential for Diabetics with Kidney Disease
Novo Nordisk’s GLP-1 drug semaglutide has scored another big win, significantly reducing the risk of death in diabetics with chronic…
Lilly Doubles Down on Tirzepatide with $8 Billion Indiana Manufacturing Megaplant
Eli Lilly and Company is investing another $5.3 billion to expand its manufacturing capacity for tirzepatide, the company’s new diabetes/obesity…
